For Immediate Release
Chicago, IL – May 29, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: T-Mobile US TMUS, Citigroup C, Blackstone Group BX, Regeneron Pharmaceuticals REGN and Canadian National Railway CNI.
Here are highlights from Thursday’s Analyst Blog:
Top Research Reports for T-Mobile, Citigroup and Blackstone
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Citigroup and Blackstone Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
T-Mobile’s shares have outperformed the Zacks National Wireless industry over the past year (+27.7% vs. +0.6%). The Zacks analyst believes that intense competition is likely to limit the company’s ability to attract and retain customers, which might affect results.
T-Mobile reported mixed first-quarter 2020 results, with the bottom line beating the Zacks Consensus Estimate and the top line missing the same. On April 1, the company closed its long-pending merger with Sprint to create a new wireless giant.
The transaction enabled T-Mobile and Sprint to join their high- and low-band spectrum for a faster nationwide 5G rollout. T-Mobile has deployed 5G sites in Philadelphia and New York City using Sprint’s 2.5 GHz mid-band spectrum on its 5G network.
However, it operates in a fiercely competitive and almost saturated U.S. telecom market. To lure customers from rivals, T-Mobile launched several low-priced service plans, which enhanced revenues, but did not improve operating margin.
Shares of Citigroup have lost 30.4% over the past six months against the Zacks Major Regional Banks industry’s fall of 29.3%. The Zacks analyst believes that Citigroup’s streamlining efforts, along with strategic investments in core business, bode well for the long term. Also, net interest revenues will likely be supported by loan growth and mix, despite low rates.
However, the company has an impressive earnings surprise history, beating the Zacks Consensus Estimate in all the trailing four quarters. Further, the company's declining costs base due to wind-down of legacy assets, supports bottom line expansion.
However, pending litigation issues might keep legal expenses elevated. Additionally, volatile equity-market revenues and underwriting business are concerns. Notably, the company has temporarily suspended share buybacks through the second quarter of 2020, following the challenges from the coronavirus pandemic.
Blackstone’s shares have gained 0.7% over the past three months against the Zacks Investment Management industry’s fall of 3.8%. The Zacks analyst believes that the company remains well-poised to gain from its fund-raising ability, revenue mix, persistent asset inflows and inorganic growth initiatives.
The company’s earnings have surpassed the Zacks Consensus Estimate in three of the trailing four quarters. Its first-quarter 2020 results were hurt by an increase in expenses, partly offset by higher revenues. Moreover, its transition from a publicly traded partnership to a corporation is expected to help in attracting more investors.
However, continuously increasing expenses (mainly owing to higher general and administrative costs) are expected to hamper the bottom line to an extent in the near term. Additionally, lower chances of sustainability of the company’s capital deployment activities remain a major concern.
Other noteworthy reports we are featuring today include Regeneron Pharmaceuticals and Canadian National Railway.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.1% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Canadian National Railway Company (CNI) : Free Stock Analysis Report
Citigroup Inc. (C) : Free Stock Analysis Report
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
Blackstone Group IncThe (BX) : Free Stock Analysis Report
TMobile US, Inc. (TMUS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research